Abstract

(Abstracted from N Engl J Med 2020;383:1340–1348) Because of the well-established association between oncogenic types of human papillomavirus (HPV) and cervical cancer, as of December 2019 a total of 124 countries and territories had implemented HPV vaccination programs. Studies have demonstrated that HPV vaccination protects against HPV infection, genital warts, and high-grade precancerous cervical lesions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call